Soru

Zorluk: ZorEndocrinology and Metabolism

Match each patient's clinical presentation and laboratory profile to the most likely underlying pathophysiologic mechanism.

  • A 68-year-old man with a long smoking history presents with confusion and a central lung mass. Laboratory studies show serum calcium 13.5 mg/dL, phosphorus 2.1 mg/dL, and intact PTH 9 pg/mL (normal 15-65 pg/mL).Secretion of a peptide homologous to parathyroid hormone
  • A 45-year-old woman is evaluated for a history of recurrent renal colic. Laboratory studies show serum calcium 11.2 mg/dL, phosphorus 2.4 mg/dL, and intact PTH 88 pg/mL.Autonomous overproduction of parathyroid hormone
  • A 24-year-old man is found to have asymptomatic hypercalcemia on routine insurance screening. Laboratory studies show serum calcium 11.4 mg/dL, intact PTH 42 pg/mL, and 24-hour urine calcium of 35 mg/day.Inactivating mutation in the calcium-sensing receptor
  • A 32-year-old African American woman presents with persistent dry cough, erythema nodosum, and bilateral facial nerve palsy. Laboratory studies show serum calcium 11.9 mg/dL, phosphorus 4.4 mg/dL, and intact PTH 12 pg/mL.Ectopic extra-renal 1-alpha-hydroxylase activity
  • A 60-year-old housebound woman presents with diffuse, dull bone pain and proximal muscle weakness. Laboratory studies show serum calcium 7.8 mg/dL, phosphorus 2.2 mg/dL, intact PTH 145 pg/mL, and elevated alkaline phosphatase.Impaired osteoid mineralization due to severe 25-hydroxyvitamin D deficiency

Cevap

The clinical vignettes represent distinct mechanisms of calcium and phosphorus dysregulation: Humoral hypercalcemia of malignancy (PTHrP), Primary hyperparathyroidism (PTH overproduction), Familial hypocalciuric hypercalcemia (calcium-sensing receptor mutation), Sarcoidosis (ectopic 1-alpha-hydroxylase), and Osteomalacia (Vitamin D deficiency).
Correct matching requires evaluating serum calcium alongside serum phosphorus, intact PTH levels, and key clinical contextual clues to determine whether the metabolic abnormality is PTH-driven, PTH-independent, or a result of a defective receptor set-point.

Adım Adım Çözüm

1
Analyze patient 1's profile
High calcium, low phosphorus, low PTH, central lung mass.
Identifies PTH-independent hypercalcemia due to malignancy (PTHrP secretion mimicking PTH effects).
2
Analyze patient 2's profile
High calcium, low phosphorus, high PTH, kidney stones.
Identifies PTH-dependent hypercalcemia caused by primary hyperparathyroidism.
3
Analyze patient 3's profile
High calcium, normal PTH, highly restricted urine calcium.
Identifies an altered calcium sensing set point indicative of Familial Hypocalciuric Hypercalcemia (FHH).
4
Analyze patient 4's profile
High calcium, high-normal phosphorus, low PTH, signs of sarcoidosis.
Identifies 1,25-dihydroxyvitamin D-mediated hypercalcemia from granulomatous macrophage activity.
5
Analyze patient 5's profile
Low calcium, low phosphorus, very high PTH, high alkaline phosphatase.
Identifies secondary hyperparathyroidism in response to severe Vitamin D deficiency causing osteomalacia.

Anahtar Kavram

Differential diagnosis of calcium and bone metabolism disorders using paired serum calcium, phosphorus, and parathyroid hormone levels.
Bu soruyu puanla